This roundtable addressed several questions concerning how payments are handled today, followed by recommendations for improving the payment process in the future:
- How do we address the differences in the level of payment by site?
- What issues do we have with Medicare payment?
- What issues do we have with the off-label use of pharmaceuticals?
- How should research be paid?
- How do we pay for survivorship, psychosocial issues, and end of life issues?
- How can we pay for cost effectiveness?
- How do we pay for quality?
- What is the patient responsibility for payment?
After the panelists addressed each of these questions, we posed the question, “If you could change payment policy, what would you do?”
Moderator:
- Peter D. Eisenberg, M.D., FACP, California Cancer Care, Inc.
Panelists:
- Michael Kolodziej, M.D., Medical Director, US Oncology, Inc
- Lee N. Newcomer, M.D., Senior Vice President, Oncology, United Healthcare
- William Rogers, M.D., FACEP, Medical Officer, Office of the Administrator, Centers for Medicaid and Medicare Services
Related Insights
14 May 2025
Energy Current
DOE Set to Eliminate Presidential Permit Requirement for Cross-Border Transmission Facilities and Streamline Electricity Export Authorizations
13 May 2025
IP Litigation Current
Alice Patent Eligibility Analysis Divergance before USPTO and District Court: Federal Circuit Clarifies Limits on Relying on USPTO Findings in § 101 Eligibility Disputes
13 May 2025
Energy Current
High-Level Overview of certain Provisions Impacting Renewable Energy Incentives in “The One, Big, Beautiful Bill” Draft Legislation
The House Ways and Means Committee released a package of tax provisions that includes claw backs of certain provisions of the Inflation Reduction Act.